Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Exchange Rate Effect (2019 - 2025)

Apyx Medical's Exchange Rate Effect history spans 7 years, with the latest figure at -$75000.0 for Q4 2025.

  • For Q4 2025, Exchange Rate Effect fell 150.0% year-over-year to -$75000.0; the TTM value through Dec 2025 reached -$466000.0, down 512.39%, while the annual FY2025 figure was -$466000.0, 512.39% down from the prior year.
  • Exchange Rate Effect reached -$75000.0 in Q4 2025 per APYX's latest filing, up from -$156000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $191000.0 in Q3 2022 to a low of -$237000.0 in Q2 2025.
  • Average Exchange Rate Effect over 5 years is -$2300.0, with a median of $5500.0 recorded in 2021.
  • Peak YoY movement for Exchange Rate Effect: skyrocketed 1011.11% in 2022, then tumbled 1347.37% in 2025.
  • A 5-year view of Exchange Rate Effect shows it stood at $129000.0 in 2021, then plummeted by 68.22% to $41000.0 in 2022, then plummeted by 151.22% to -$21000.0 in 2023, then skyrocketed by 814.29% to $150000.0 in 2024, then plummeted by 150.0% to -$75000.0 in 2025.
  • Per Business Quant, the three most recent readings for APYX's Exchange Rate Effect are -$75000.0 (Q4 2025), -$156000.0 (Q3 2025), and -$237000.0 (Q2 2025).